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Abstract 
Sox2 is a transcription factor active in the nervous system, within different cell types, ranging  
from radial glia neural stem cells to a few specific types of differentiated glia and neurons. 
Mutations in the human SOX2 transcription factor gene cause various central nervous system 
(CNS) abnormalities, involving hippocampus and eye defects, as well as ataxia. Conditional 
Sox2 mutation in mouse, with different Cre transgenes, previously recapitulated different 
essential features of the disease, such as hippocampus and eye defects. In the cerebellum, 
Sox2 is active from early embryogenesis in the neural progenitors of the cerebellar 
primordium; Sox2 expression is maintained, postnatally, within Bergmann glia (BG), a 
differentiated cell type essential for Purkinje neurons functionality and correct motor control.  
By performing Sox2 Cre-mediated ablation in the developingand postnatal mouse cerebellum, 
we reproduced ataxia features. Embryonic Sox2 deletion (with Wnt1Cre) leads to reduction of 
the cerebellar vermis, known to be commonly related to ataxia, preceded by deregulation of 
Otx2 and Gbx2, critical regulators of vermis development. Postnatally, BG is progressively 
disorganized, mislocalized, and reduced in mutants. Sox2 postnatal deletion, specifically 
induced in glia (with GLAST-CreERT2), reproduces the BG defect, and causes (milder) ataxic 
features. Our results define a role for Sox2 in cerebellar function and development, and 
identify a functional requirement for Sox2 within postnatal BG, of potential relevance for 
ataxia in mouse mutants, and in human patients. 
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Main points 
-Deletion of Sox2 in the cerebellar primordium leads to ataxic symptoms, with vermis 
hypoplasia and Bergmann glia dysmorphology and displacement 
-Postnatal Sox2 deletion in glia causes mild ataxia with Bergmann glia defects 
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Introduction 
 
The Sox2 transcription factor is widely expressed in the developing central nervous system 
(CNS), from early embryogenesis (Bertolini, 2016; Pevny & Nicolis, 2010).  In humans, Sox2 
heterozygous mutations lead to a spectrum of CNS defects, including eye defects, hippocampal 
reduction, seizures, as well as motor control defects and ataxia (Bertolini, 2016; Dennert et al., 
2017; Ragge et al., 2005; Sisodiya et al., 2006). In mouse, complete Sox2 loss is early 
embryonic lethal (Avilion et al., 2003); by conditional knock-outs and hypomorphic mutants, 
we and others demonstrated that Sox2 loss leads to important CNS defects, affecting the eye, 
the developing ventral forebrain, and the hippocampus. Most of these defects arise as a 
consequence of the loss of neural stem cells (represented by radial glia), although in some 
cases specific glial or neuronal types have been involved (Cavallaro et al., 2008; Favaro et al., 
2009; A. Ferri et al., 2013; A. L. Ferri et al., 2004; Pevny & Nicolis, 2010).  
Ataxia is a motor control defect, depending on cerebellar abnormalities, and is often the 
consequence of inherited genetic defects observed in man (Basson & Wingate, 2013; Leto et 
al., 2016). While the genetic defects primarily operates in neurons in most types of ataxias, at 
least in two cases (SCA1, SCA7) Bergmann glia (BG), a specialized cerebellar glia essential for 
Purkinje neurons functionality, critically contributes to the defect; the BG dysfunction affects, 
in a non-cell-autonomous way, the functions of the adjacent Purkinje neuronal cells (PC), 
which are responsible for the functional defects (Buffo & Rossi, 2013; Custer et al., 2006; 
Shiwaku et al., 2010). While the primary genetic defect is well defined, the network of gene 
regulation and protein interactions downstream to it are not yet well understood.  
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Previous studies of hypomorphic Sox2 mutants demonstrated motor abnormalities (Ferri 
2004); in this work, we investigated the possibility that Sox2 conditional ablation in mouse 
reproduces some of the ataxic features demonstrated in human patients. To this end, we 
ablated Sox2 either prenatally, or postnatally, within the cerebellum, a CNS region essential in 
the control of movement, whose disfunction leads to ataxias (Basson & Wingate, 2013; Leto et 
al., 2016). We report that prenatal Sox2 loss in the developing midbrain-hindbrain region (via 
Wnt-1-Cre-mediated deletion) leads to a reduction of the cerebellar vermis at birth, and, 
postnatally, to progressive disorganization, mislocalization and reduction of BG, functionally 
accompanied by ataxia. BG retains Sox2 expression postnatally, and we find that postnatal 
deletion of Sox2 in glia (via GLAST-CreERT2) also leads to BG disorganization, mislocalization 
and reduction. Our findings point to a novel role for Sox2 in the postnatal establishment of the 
correct phenotype, layering and functions of this important cerebellar cell type. 
 
Materials and methods 
 
Experimental animals 
Experiments were performed on different mouse lines: Sox2flox (Favaro et al., 2009), Wnt1Cre 
(Danielian, Muccino, Rowitch, Michael, & McMahon, 1998), GLASTCreErt2 (always used as 
heterozygous) (Buffo et al., 2008; Mori et al., 2006). Either sex was included. The day of 
vaginal plug detection was defined as embryonic day zero (E0) and the day of birth was 
considered as postnatal day zero (P0). Mice were maintained on a 12 hrs day ⁄ night cycle 
with adequate food and water. All procedures were in accordance with the European 
Communities Council Directive (2010/63/EU and 86/609/EEC), the National Institutes of 
Health guidelines, and the Italian Law for Care and Use of Experimental Animals (DL26/14). 
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They were approved by the Italian Ministry of Health and the Bioethical Committees of the 
Universities of Milan and Turin.  
 
Histological, in situ hybridization and immunohistochemical procedures 
In situ hybridization was performed as in (Favaro et al., 2009; A. Ferri et al., 2013). Briefly, 
embryos were fixed in 4% paraformaldehyde (PFA) in 0.12 M phosphate buffer (PB), pH7.2–
7.4, cryoprotected, embedded in OCT and sectioned on a cryostat at 20 µM. Antisense probes 
for Sox2 (Avilion et al., 2003), Otx2 (Acampora, Avantaggiato, Tuorto, & Simeone, 1997) and 
Gbx2 (Wassarman et al., 1997), a kind gift (Otx2; Gbx2) from Drs. L. Muzio and V. Broccoli, 
were in vitro transcribed in the presence of DIG-UTP and hybridized to sections at 65°C. The 
signal was visualized by incubation with BM-purple (Sigma). For postnatal brain analysis, 
animals were transcardially perfused under anesthesia (hypothermia for pups up to postnatal 
day –P-7 and intraperitoneal injection of a mixture of ketamine -100 mg/kg; Ketavet, Bayern, 
Leverkusen, Germany- and xylazine -5 mg/kg; Rompun, Bayer, Milan, Italy- for older mice) 
with an appropriate volume of 4% PFA in 0.12 M phosphate buffer (PB), pH7.2–7.4. Brains 
were removed, stored overnight (o/n) in the same fixative at 4 °C, washed in Phosphate 
Buffered Saline (PBS) and finally cryoprotected in 30% sucrose in 0.12M PB. The cerebella 
were then embedded and frozen over dry ice in OCT (TissueTEK), sectioned in the 
parasagittal plane at 30 μm using a cryostat and collected in PBS (P30 juvenile and adult 
cerebella) or placed directly onto glass slides (E13-P7 cerebella). For immunolabelling, 
sections were incubated o/n at room temperature with the appropriate primary antibodies 
dissolved in PBS with 1.5% donkey or goat serum (Jackson ImmunoResearch) and 0.25% 
Triton X-100 (Sigma-Aldrich): anti-S100BETA (S100B, 1:1000, mouse, monoclonal; Sigma), 
anti-glial fibrillary acidic protein (GFAP, 1:1500, rabbit, polyclonal; Dako), anti-brain lipid 
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binding protein (BLBP, 1:500; rabbit, polyclonal; Abcam); anti-SOX2 (1:500, rabbit, 
polyclonal; Merck Millipore;  1:50, mouse, monoclonal, R&D Systems); anti CALBINDIN(CALB, 
1:1500, rabbit, monoclonal; Swant); anti-PARVALBUMIN (1:1500, mouse monoclonal; Swant); 
anti-myelin basic protein (MBP, 1:1000, mouse, monoclonal; BioLegend); anti-NG2 (1:250, 
rabbit, polyclonal; Merck Millipore); anti-Glutathione S-Transferase, Pi isoform (GSTPi, 1:500, 
rabbit, polyclonal; Eppendorf); anti-OLIG2 (1:500, rabbit, polyclonal; Merck Millipore). 
Sections were then exposed for 2h at room temperature to secondary species-specific 
antibodies conjugated with Alexa Fluor 488, Alexa Fluor 555 or Alexa Fluor 647 (1:500; 
Invitrogen), or Cy3 (1:500; Jackson ImmunoResearch). Cell nuclei were visualized using 4’,6-
diamidino-2-phenylindole (DAPI; Fluka). After processing, sections were mounted on 
microscope slides with Tris-glycerol supplemented with 10% Mowiol (Calbiochem). 
Statystical detail on Immunofluorescence cell counting is in Supplementary Table 2 and 
Figure legends. 
 
Image processing and morphometric analyses 
Histological specimens were examined using an E-800 Nikon microscope connected to a 
color CCD camera or a Leica TCS SP5 confocal microscope. Adobe Photoshop 6.0 (Adobe 
Systems) was used to adjust image contrast and assemble the final images. On the basis of 
confocal images, ectopia, densities, lengths and distances were mapped and quantified by 
Neurolucida 7.0 (MBF Bioscience) or by NIH ImageJ (http://rsb.info.nih.gov/ij/) softwares. 
Numbers of analysed animals for each time point or experimental condition are shown in the 
figure legends. Measurements were derived from at least three sections per animal. For 
evaluation of oligodendrocyte precursors and mature oligodendrocytes densities, cell counts 
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were performed in two areas of lobules IV-V and IX, on confocal stacks of about 25 µm. Three 
sections per animal were examined. 
The thickness (t) of the granular cell layer (GL) was determined on DAPI labelled slices 
according to the formula t = 2 A/b1 + b2, as in Carulli et al (2002). “A” was given by the area 
defined by the outer and inner profile of the granular layer, and “b1” and “b2” were the 
lengths of the two profiles. At least three slices/animal and three animals/genotype were 
analyzed. Values were pooled to yield the final average thickness.  
For morphometric measurements in adult mice, DAPI-stained sections next to the midline of 
the entire cerebellar vermis were analysed. The whole PCL length, the extension along the 
Rostro-Caudal (R-C) and Ventro-Dorsal (V-D) axes, the PCL length along each lobule and the 
extension of the fissures between lobules VIa-VIb and IXb-IXc were evaluated using a 
fluorescent microscope and traced by means of the Neurolucida software (MicroBrightfield). 
For the of R-C extension measurement, the points of maximal convexity of the crowns of 
lobules V and IXb were chosen as points of reference, whereas the length of the V-D axis was 
evaluated by measuring the distance from the invagination between lobules I and X (maximal 
concavity) and the midpoint in the crown of lobule VIb. The length of the PCL along each 
lobule was measured as the line connecting the midpoint of the basis of the two fissures 
preceding and following the folium of interest. The extension of the fissures was evaluated by 
measuring the length of PCL between the related inward indentation points. For evaluation of 
BG ectopia, BG densities and BG to PC ratios, cell counts were performed in three cortical 
areas of lobules III, IV-V and IX, on confocal Z stacks of about 15 µm. Three sections per 
animal were evaluated. 
 
Systemic administration of Tamoxifen 
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To activate the Cre recombinase in GLASTCreERT2 Sox2 mice Tamoxifen (Tx) (20 mg/ml 
solution dissolved in corn oil) was administered via subcutaneous injection for pups (20 μg/g 
body weight) or via oral gavage for adults (5 mg/40 g body weight). Mice were given either a 
single Tx injection at P2 or administered a double treatment including a first single injection 
at P8 and a further treatment at P60. A distinct cohort of adult mice was treated at 4 months 
of age to assess the effects of Sox2 deletion after the completion of cerebellar maturation. 
However, at 2 months after treatment no changes in BG layering were observed, suggesting 
that Sox2 is dispensable to preserve BG morphology and layering at adult stages, when 
cerebellum maturation is fully accomplished. As for experiments performed in Wnt1-Cre Sox2 
mice, animals with mixed genotypes were used as controls (Sox2F/+;CreERT2, Sox2FF or 
Sox2F/+) for some analyses. In other instances, Sox2F/F;CreERT2 mice with no Tx treatment 
were also employed as controls, as indicated in Supplementary Table 1. 
 
Behavioural Assays 
All behavioral experiments were conducted in a dedicated dimly illuminated (2 x 40 W 
indirect) testing room during the standard light phase, usually between 9:00 AM and 2:00 PM 
(rotarod from 10:00 AM to 12:00 AM, beam test from 10:00 AM to 1:00 PM, open field from 
10:00 AM to 2:00 PM). In all tests, the cages containing mice were moved into the testing 
room 1 hour before the first trial began. For Wnt1-Cre Sox2 mutants of either sexes were 
examined and pooled together, as no difference was appreciated between genders. For 
GLASTCreERT2 Sox2 mutants, in cases of relevant differences data for males and females are 
presented separately. 
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Rotarod test. Motor coordination, balance and motor learning were assessed using an 
accelerating rotarod (Ugo Basile, Varese, Italy; (Fuca et al., 2017)). The rotarod apparatus had 
five flanges dividing the five 5.7 cm lanes, the cylinder diameter was 3.5 cm. Mice were placed 
on the rotating bar and given a habituation period of 2 min at constant velocity (5.5 rpm), 
after which the rotating bar accelerated from 5.5 to 60 rpm over 300 seconds. Mice were put 
on the rotarod until the latency to fall off reached the total time of 300 s. Three trials per day 
with 3-5 min intervals, on three consecutive days were performed; we considered the 
averages of the three sessions. During pauses between trials, mice rested in their home cages  
 
Beam walking test. In order to assess balance capabilities, beam walking test has been used 
(adapted from (Hilber & Caston, 2001)). Testing was performed once for month for mice of 
each group. The apparatus consisted of a motionless wooden beam with a rectangular section 
(1 cm x 3 cm), 1 m in length, placed 80 cm above a foam carpet. At the onset of the single trial, 
each animal was placed at one extremity of the beam, its body axis being perpendicular to the 
beam long axis. We recorded the time spent to complete each cross and the number of paw 
faults or slips made during the passages to the wooden bar, for a final number of 5 crossings 
of the bar. Then, for each animal, the frequency of slip and the time spent to cross the 
beamwere calculated. After 5 consecutive, unsuccessful trials to stay on the bar, the test was 
considered failed.  
 
Open field. Animals were tested in a forex arena (50 x 50 cm), which was divided into a 
central (25 x 25 cm) and a peripheral zone (Cupolillo et al., 2016). The animal was placed in 
the corner of the open field and was allowed to explore the arena for 10 min. Distance 
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travelled and time spent in the central zone was recorded and analyzed by Ethovision XT 
video track system (Noldus Information Technology, Wageningen, Netherlands). 
 
Electrophysiology 
The animals were anesthetized with isoflurane (Isoflurane-Vet, Merial, Italy) and decapitated. 
The cerebellar vermis was removed and transferred to an ice-cold artificial cerebrospinal 
fluid (ACSF) containing (in mM); 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 26 
NaHCO3, 20 glucose, which was bubbled with 95% O2/5% CO2 (pH 7.4). Parasagittal 
cerebellar slices (200 μm thickness) were obtained using a vibratome (Leica Microsystems 
GmbH, Wetzlar, Germany) and kept for 1 h at 35°C and then at 25°C. Single slices were placed 
in the recording chamber, which was perfused at a rate of 2–3 ml/min with ACSF bubbled 
with the 95% O2/5% CO2. All recordings were performed at room temperature (22–25°C). 
The data derive from 5 to 7 animals. 
Whole-cell patch-clamp recordings were made from PCs of adult animals of both genotypes 
using an EPC-9 patch-clamp amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). We 
performed recordings in the posterior lobules of cerebellum. Pipettes of borosilicate glass 
with resistances between 2.5 and 3.0 MΩ were used. Patch pipettes were filled with an 
internal solution containing (in mM): 130 CsCl, 4 MgCl2, 10 HEPES, 4 Na2ATP, 0.4 Na3GTP, 10 
EGTA, 5 N-(2,6-dimethylphenyl)acetamide-2-triethylammonium bromide (QX-314) and the 
pH was adjusted to 7.3 with CsOH and filtered at 0.2 µm. Cs+ blocks most outward currents 
through K+ channels while QX-314 blocks voltage-gated Na+ channels. Recordings were 
accepted only if the series resistance was less than 9.0 MΩ (range: 5.0–9.0 MΩ), and if it did 
not vary by >20% during the experiment. Data were filtered at 3 kHz and sampled at 10 kHz. 
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For all the experiments, digitized data were stored on a personal computer using the Patch 
Master software (HEKA Elektronik, Lambrecht/Pfalz, Germany) and analized off-line.  
PF-EPSCs were evoked by stimulating the PFs in the molecular layer while the PC was kept at 
a holding potential of -90 mV. The stimulation was done with a glass pipette, pulled from 
sodalime glass to a tip diameter of 10–15 µm, containing the saline solution. Negative current 
pulses ranging from 3 to 15 µA with a duration of 100µs were delivered at 20s intervals. 
Paired pulse facilitation was elicited by applying double pulses of 9 µA of intensity at different 
time intervals (50, 100, 150, 200 ms), and the ratio of the amplitude of the second PF-EPSC 
over the first one was calculated. All PF recordings were performed in the presence of 
gabazine (SR 95531, 20 µM) in the saline solution. 
 
Gliosome purification 
Animals were euthanized and the whole brain rapidly removed. The cerebellar cortex was dissected 
on ice at 4°C; care was taken to dissect away the white matter, containing fibrous (parenchymal) 
astrocytes, as much as possible, to obtain an astrocyte preparation highly enriched in BG; glial 
perisynaptic processes (gliosomes) were then prepared from control and Sox2F/F;Wnt1Cre 
mutant mice essentially as previously described (Milanese et al., 2010; Raiteri et al., 2008), 
with minor changes. Briefly, the tissue was homogenized in 0.32 M sucrose, buffered at pH 7.4 
with Tris-HCl, using a glass-teflon tissue grinder (clearance 0.25 mm - Potter-Elvehjem VWR 
International). The homogenate was centrifuged (5 min, 1,000 x g) to remove nuclei and 
debris, the supernatant centrifuged at 12,000 x g for 10 min and the pellet resuspended in 
Tris-buffered 0.32 M sucrose and gently layered on a discontinuous Percoll® (Sigma-Aldrich, 
St Louis, Missouri, USA) gradient (2, 6, 10 and 20% v/v in Tris-buffered 0.32 M sucrose). After 
centrifugation at 33,500 x g for 5 min, the layer between 2 and 6% Percoll® (gliosomal 
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fraction) was collected and washed by centrifugation at 20,000xg for 15 min with 
physiological medium (PM) having the following composition (mM): NaCl, 140; KCl, 3; MgSO4, 
1.2; NaH2PO4, 1.2; NaHCO3, 5; CaCl2, 1.2; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 10; glucose, 10; pH 7.4. Gliosomes were re-suspended in PM for uptake experiments 
or lysed in Ultrapure water (Milli-Q; Millipore, Billerica, MA, USA) for endogenous 
glutamate/glutamine determination. All the above procedures were conducted at 4°C. Protein 
content was measured according to (Bradford, 1976) using bovine serum albumin (Sigma-
Aldrich, St Louis, Missouri, USA) as a standard.  
 
Uptake experiments 
Uptake was measured in gliosomes purified from BG-enriched glia of control (Sox2FF/F+) and 
mutant (Sox2F/F;Cre) mice as previously described (Milanese et al., 2015). Briefly, gliosomes 
were re-suspended in PM and aliquots (500 µl, corresponding to 3-5µg protein) were 
incubated for 5 min at 37 °C and the 20µl of a solution of [3H]D-Aspartate ([3H]D-Asp)(specific 
activity: 16.5 Ci/mmol, Perkin Elmer Italia, Milan, Italy), a non-metabolizable analogue of 
glutamate (Glu), used to mimic the endogenous neurotransmitter as a substrate of Glu 
transporters (Raiteri et al., 2007) was used, to obtain the final concentrations of 0.3, 3, 5, 30, 
and 100µM.  After 2 min incubation at 37°C, [3H]D-Asp uptake was blocked by rapid vacuum 
filtration on glass fiber filters (GF-B, Millipore, Billerica, MA, USA) and washed three times 
with 5 ml of standard medium to remove the excess of radioactivity. Aliquots of gliosomes 
were exposed to the same concentrations of [3H]D-Asp at 0–4 °C in the presence of 50µM of 
the broad spectrum Glu uptake inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA; Tocris 
Bioscience, Bristol, UK; Shimamoto et al., 1998) to detect the non-specific binding to the 
gliosomal membranes. Radioactivity was determined by liquid scintillation counting. The 
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specific uptake was calculated by subtracting non-specific binding from the total uptake. To 
calculate the kinetic parameters Vmax and Km for the two experimental groups, data were 
fitted by the Michaelis-Menten equation V=Vmax*[S]/Km+[S], using the SigmaPlot 10.0 and 
SigmaStat fitting setup (Systat Software, Inc., San Jose, CA, USA).  
 
 
Endogenous glutamate and glutamine determination 
BG cells gliosomes from control (Sox2FF/F+) and mutant (Sox2F/F;Cre) mice were lysed in 
hypotonic ultrapure water, and the cytosolic extracts separated from membrane debris by 
centrifugation (10 min 20,000xg). The endogenous glutamate and glutamine content were 
quantified in supernatants by previously described high performance liquid chromatography 
analysis (Milanese et al., 2011). The methods consisted in a pre-column derivatization of the 
samples with o-phthalaldehyde, followed by discontinuous gradient separation using a C18 
reverse-phase chromatographic column (Agilent MicroSpher C18, S100x4.6, 3 µm; CPS 
Analitica, Milano, Italy) at 30 °C, and fluorometric detection (excitation wavelength 350 nm; 
emission wavelength 450 nm;). Homoserine (Sigma-Aldrich, St. Louis, MO, USA) was used as 
an internal standard.  
 
Statistical analyses 
Data elaboration and statistical analyses were conducted by means of GraphPad software 
Prism version 7.0 (GraphPad software, San Diego; SPSS,IBM) In all instances, *P<0.05 was 
considered as statistically significant, **P<0.01 very significant and ***P<0.001 extremely 
significant. Graphs and data are represented as means ± standard errors. If data sets passed 
normality test and equal variance test, we performed Student's t-test or One/Two Way Anova 
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followed by Bonferroni post hoc tests. When data did not satisfy the normality or equal 
variance tests, corresponding non-parametric statistics was used. To compare different 
percentages, we transformed the values in radiants according to the arcsin transformation. 
Cumulative frequency plots were analyzed by Kolmogorov-Smirnov (KS) test. The graphs of 
electrophysiology results were designed using Igor Pro (WaveMetrics, Lake Oswego, Oregon, 
USA). Details about statistical assessment and numerical values obtained are provided in 
Supplementary Tables 1 and 2. 
 
RNAseq from wild type and mutant neural stem cell-derived in vitro differentiated cells 
Neurosphere cultures were derived from wild type and Sox2-mutant mouse forebrain cells. 
Sox2 ablation was obtained at E11.5 by Nestin-Cre deletion; at P0, neural stem cells 
populations from three wild type and three Sox2 mutant forebrains, were   individually placed 
in culture  (in the presence of EGF and FGF) to generate neurospheres (as in Favaro et al. 
2009). For differentiation, neurospheres from the individual cultures were dissociated to 
single cells, and plated onto MATRIGEL (Becton-Dickinson)-coated tissue culture dishes at 1,5 
x 106 cells/10cm dish (Gritti et al., 1996; Zappone et al., 2000), with bFGF only as mitogen. 
After 4 days, the medium was changed to neural stem cell medium without bFGF, and 
supplemented with 1% fetal calf serum (FCS). At day eleven, cells were collected for RNA 
analysis (at this stage, over 90% of the cells are glial cells in wild type cells, and about 95% in 
mutant cells). RNA extraction was performed on the three independent NSC populations for 
both wild type and mutant cells, using Trizol and RNeasy Kit (Qiagen). 1/5 volume of 
chloroform was added to one volume of Trizol.  The aqueous phase was transferred into a 
new tube. 1.5x volume of ethanol was added and thoroughly mixed. The mixture was filtered 
through Rneasy (Qiagen) columns; the columns were washed with Buffer RW1. On-column 
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DNase treatment was performed as described by the RNase-Free DNase Kit (Qiagen). Post 
treatment columns were cleaned up with Buffer RW1 and two washes of RPE buffer. Columns 
were then dried and total RNA was eluted with RNase-free water. PolyA Stranded Truseq 
Libraries were generated using the Truseq Stranded mRNA Sample Preparation Kit 
(Illumina). First, mRNA was purified from 1µg of total RNA using magnetic beads containing 
poly-T oligos. mRNA was then fragmented and reverse transcribed using Superscript II 
(Invitrogen), followed by second strand synthesis. Double stranded cDNA was treated with 
end-pair, A-tailing, adapter ligation and 8 cycles of PCR amplification. 
RNA-Seq was performed on all individual samples (three wild type and three mutant) studied, 
to yield single-end reads. The number of sequences obtained in each sample ranged from 7.5 
to 12.5 millions. 
Read counts and transcript levels for each sample were computed with the RSEM software 
package version 1.17 (B. Li & Dewey, 2011), on the RefSeq gene annotation available at the 
UCSC Genome Browser for mouse genome assembly mm9 (24,148 genes). For downstream 
analyses, expression levels measured as Transcripts per Million (TPM) were employed.  
Differential expression analysis was performed with the NOISeqR package (Tarazona et al., 
2015). Differentially expressed genes were selected by employing a q-value threshold of 0.99, 
corresponding to an empirical false discovery rate (FDR) of 0.01. 
 
 
Results 
 
Conditional Sox2 mutants develop ataxia 
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To address the consequences of Sox2 loss in the developing cerebellum, we used mice 
carrying a Sox2flox conditional knockout (cKO) allele, previously generated in our laboratory 
(Favaro et al., 2009); to delete Sox2, we used Wnt1-Cre, active from embryonic day 9.5 (E 9.5) 
in the developing midbrain-hindbrain region, where the cerebellum will arise (Danielian et al., 
1998). In situ hybridization at E9.5 in wild type embryos shows Sox2 mRNA expression in the 
neuroepithelium (consisting, at this stage, of undifferentiated progenitors of neurons and 
glia), throughout the developing neural tube, including the midbrain-hindbrain region where 
the cerebellum will arise; in the mutant, Sox2 mRNA was lost in the developing 
mesencephalon and anterior rhomboencephalon by E9.5 (Fig. 1a). 
Wnt1-Cre Sox2 mutant mice (Sox2F/F;Cre hereafter) are born in normal mendelian ratios; 
most survive to adulthood, though a few are lost before weaning (when mutants represent 
20% of the offspring, instead of the expected 25%).   
We initially observed clear motor abnormalities in a number of adult mutant mice, suggesting 
possible cerebellar defects.  To precisely address functional cerebellar abnormalities in Sox2 
mutants, we subjected them to behavioural tests of motor coordination and equilibrium, used 
to detect alterations that arise following cerebellar damage: the rotarod and balance beam 
tests (Fuca et al., 2017; Hilber & Caston, 2001). We compared motor performances of mutants 
and control littermates between 1 and 8 months of life (Fig. 1b-d). By the rotarod test, latency 
to fall (whose shortening is indicative of motor control damage) was significantly shorter 
from 2 months of age (Fig. 1b). Heterozygous (Sox2F/+;Cre) mice also showed a moderately 
reduced latency, though the defect was less pronounced than that of homozygous mutants 
(Fig. 1b). The beam-walking test revealed a significant impairment of the Sox2F/F;Cre 
mutants as compared to controls, not only in the execution of the test, with a significantly 
higher number of slips (Fig. 1c), but also in the time needed to complete the crossings on the 
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beam bar, especially at the earliest time points (Fig. 1d). Thus, Sox2 deletion during cerebellar 
development leads to defects in fine motor coordination and balance. 
 
Wnt1-Cre-mediated Sox2 deletion leads to morphological cerebellar abnormalities  
To understand the causes of the observed ataxic defects, we studied the mutant cerebellum 
during development and postnatally. Sox2 deletion at E9.5 via Wnt1-Cre results in early 
posterior shifts of the expression boundaries of two genes, Otx2 and Gbx2, and an early 
thinning of the neuroepithelium in the medial, prospective vermis region (Supporting 
Information Fig. S1). Otx2 and Gbx2 encode transcription factors required for the precise 
spatial definition of the isthmic organizer, a signalling center marking the boundary between 
prospective mesencephalon and cerebellum, and for subsequent vermis development (Joyner, 
Liu, & Millet, 2000; J. Y. Li, Lao, & Joyner, 2002; Martinez, Andreu, Mecklenburg, & Echevarria, 
2013; V. Y. Wang & Zoghbi, 2001); the correct relative positioning of Otx2 and Gbx2 
expression territories is critical for the appropriate development of the isthmic organizer 
(Broccoli, Boncinelli, & Wurst, 1999).  
At birth, abnormalities of cerebellar morphology were observed (Fig. 1e, showing postnatal 
day 5, P5). The most prominent defects were seen in the medial region, the vermis, which was 
underdeveloped, in particular along its antero-posterior axis (Fig. 1e,f). Different degrees of 
severity were observed: from severe reduction (Fig. 1e, far right; “severe” mutants, 11% of 
total) to milder (though visible) effects, in all other mutants (Fig. 1e left; “moderate” 
phenotype). 
We addressed cerebellar vermis morphology in more detail in three adult mutants (8 months, 
moderate phenotype), by morphometric analyses (Fig. 2). Vermis alterations were observed 
in all three mutants:  measurements of the total length of the Purkinje cell layer (PCL), and of 
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the rostro-caudal vermian axis, revealed a reduction in size, with no changes in the thickness of 
the granule layer (GL) (Fig.  2e-h). Consistent with this result, also PCL lengths in various 
specific lobules were shorter compared to controls; this reduction was most prominent in 
lobules IV/V, VIb, and IX and X (20-60% reduction; these lobules are particularly important 
for equilibrium and posture) (Fig 2i-k). More subtle alterations in foliation were also 
detected; indeed, the late-born secondary fissure separating lobule IXb/IXc was not observed 
in mutants, and the VIa/VIb fissure showed a trend to decrease in length (Fig. 2a,b,c,l,m).  
 
Sox2 mutants show alterations of Bergmann glia monolayer formation arising postnatally 
To further investigate possible mechanisms for the mutant phenotype, we looked for 
abnormalities at the cellular level within the postnatal cerebellum, where neurons and glia 
complete their terminal differentiation and acquire their function.   
We first looked at Sox2 expression in the wild type postnatal cerebellum, by double 
immunofluorescence for SOX2 and cell-type-specific antibodies. At early postnatal ages, SOX2 
was clearly expressed in S100B-positive BG (Fig. 3a-b’’), though apparently not in adjacent, 
CALBINDIN-positive PCs (Fig. 3c-c’’’), in agreement with previous reports (Shiwaku et al., 
2010; Sottile, Li, & Scotting, 2006). SOX2 was also expressed by parenchymal astrocytes of the 
GL and prospective white matter (PWM; Fig. 3a-b), as expected (Sutter et al., 2010). The same 
pattern of expression was maintained in adult cerebella at 8 months of age (Fig. 3d-d’’’). In 
Sox2F/F; Cre mutant mice, Sox2 was not detected, as expected (Fig. 3e-f’).  
 
We then looked at possible alterations, in mutants, within specific postnatal cell types, by 
immunofluorescence with cell type-specific markers, at P7, P19 and 8 months. At 8 months, 
we did not detect major changes in the density, nor morphology, of PCs, nor of interneurons 
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(by CALBINDIN and PARVALBUMIN immunofluorescence, respectively) in mutants compared 
to controls (Supporting Information Fig. S2). As Sox2 is expressed in oligodendrocyte 
progenitors during development (Zhao et al., 2015), we also examined oligodendrocytes by 
immunofluorescence using anti-NG2 (recognizing immature oligodendrocyte progenitors), 
GSTPi (post-mitotic differentiating oligodendrocytes) and Olig2 (the entire oligodendrocyte 
lineage): no significant differences in the density or distribution of labelled cells was observed 
at 10 weeks of age (Supporting Information Fig. S3a-c’’’). In addition, overall myelination, as 
detected by MBP immunofluorescence, was not altered in mutant as compared to control mice 
(Supporting Information Fig. S3d-e’’). We then investigated glial cells, which have essential 
roles in the maintenance of cerebellar neuronal function. In particular, BG cells, which express 
Sox2 (Fig. 3), surround with their cell bodies the PC, enwrap their cell dendrites, and are 
critical for their function (Buffo & Rossi, 2013; Custer et al., 2006; Miyazaki et al., 2017). We 
performed immunofluorescence with antibodies against BLBP (recognizing BG progenitors at 
P7), and S100B and GFAP (recognizing fully differentiated glia cells, in particular BG, at later 
stages) (Fig. 4a-r). At P7, mutant cerebella did not reveal overt differences in BLBP- or S100B-
positive glial cell number, morphology, or localization, when compared to the two control 
genotypes (Sox2F/F, Sox2F/+, or Sox2F/+; Cre ; ‘controls’)(Fig. 4, compare m-o, mutant, with 
a-c and g-I , controls). At P19, however, abundant S100B/GFAP-positive cell bodies suggestive 
of mislocalized BG cells were observed in the molecular layer (ML) of the mutant, (Fig. 4p-p’’), 
in contrast with the orderly alignment of S100BETA/GFAP-positive cell bodies along the PCL, 
with parallel radial projections extending across the ML, observed in controls (Fig. 4d-d’’, j-j’’). 
GFAP immunofluorescence (staining the cytoplasm more intensely than S100B) further 
showed that ectopic cells had a non-radial, abnormal morphology (Fig. 4p’’, arrowheads). 
These ectopic cells were still abundant at 8 months (Fig. 4, compare q-r, mutant, to e-f and k-l, 
Page 22 of 64
John Wiley & Sons, Inc.
GLIA
  
 
22
controls; quantitation in s), and GFAP immunofluorescence highlighted a characteristic 
aberrant, multipolar morphology, with dense arborizations (Fig. 4r, arrowheads).  The 
abnormal cell morphology was particularly evident in the ectopic cells (Fig. 4r’, inset), but also 
occasionally observed on the cells aligned along the PCL (Fig. 4r, arrows). Overall, the number 
of non-ectopic BG in the mutant PCL was significantly decreased compared to control animals 
(Fig. 4t,u).  Importantly, by contrast with the abnormalities in mutant BG, parenchymal 
astrocytes of the GL and WM appeared unchanged among genotypes (Supporting Information 
Fig. S2). We conclude that the localization and morphology of glial cells (BG, based on the 
location) are progressively altered during postnatal life in Wnt1Cre-Sox2 mutant mice. 
 
Alteration of synaptic transmission at parallel fiber-Purkinje cell synapse 
Given the important role of BG in modulating the excitatory synapse transmission in PCs, we 
examined synaptic transmission between parallel fibers (PFs) and PCs by means of whole-cell 
voltage clamp. We performed our analysis in adult mice, in the posterior lobules of the 
cerebellum, which had revealed the most prominent reduction of the PCL length (Fig. 2). We 
electrically stimulated PFs using a stimulation electrode placed in the molecular layer and 
recorded excitatory glutamatergic synaptic currents (PF-EPSCs) in the PC. PF-EPSCs had 
comparable amplitudes at every intensity of stimulation in both mutant (n = 16 cells) and 
control mice (n = 17 cells) (P> 0.05, Two- way ANOVA repeated measures –RM-) (Fig 5a-b). 
However, while most EPSCs of control mice had amplitudes smaller than 250 pA with 
stimulus strength of 12 µA (Fig 5c), a large fraction of mutant mice EPSCs exceeded this value 
(Fig 5d). Cumulative plots revealed significant differences between genotypes in the 
distribution of EPSC amplitudes, with mutant values shifted to the right towards larger values 
(KS, P<0.0001) (Fig 5e). To evaluate possible alterations in glutamate release from 
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presynaptic terminals we stimulated PFs with paired stimuli at different intervals. The 
analysis of paired pulse facilitation of the PF-PC synapse did not show differences between 
genotypes, suggesting a preserved presynaptic release of glutamate by PFs (P>0.05, Two way 
Anova RM) (Fig 5f-g). Alterations of BG are associated with changes in the kinetics of PF-
EPSCs (Takayasu et al., 2005). To address this issue we measured the decay time constant of 
PF-EPCSs. We did not find changes between genotypes in the decay time constant (for 
controls: 19.26±1.45ms; for mutant mice: 18.36±2.25ms P>0.05, Student’s t-test). However, 
the analysis of the distribution of decay time constants of mutant mice EPSCs revealed the 
presence of two populations with faster and slower decays (data not shown), while the data of 
control mice were better described as a single population. The heterogeneity of the synaptic 
properties of the EPSCs is in line with the presence of ectopic BG, which might alter synaptic 
transmission at nearby synaptic contacts. 
 
Sox2 postnatal deletion in radial glia leads to ectopic, abnormal and disorganized Bergmann 
glia and to mild motor control defects  
The expression of SOX2 in postnatal BG, together with the defects in BG observed in mutants, 
raised the possibility that SOX2 could be required postnatally, within the BG itself, to maintain 
these cells and their characteristics. To test this hypothesis, we deleted Sox2 in BG 
postnatally, by means of a tamoxifen (Tx)-inducible Cre encoded by a GLASTCreERT2 transgene 
(Buffo et al., 2008; Mori et al., 2006).  Tx was administered at P2 or P8, and cerebella were 
analysed at 1 or 8 months of age (Fig. 6).  Cre induction leads to efficient ablation of SOX2 
from S100B-positive BG, reaching 60-80% (Fig. 6c-d, mutant, compare to a-b, controls; 
quantitation in e). In controls, at P30, the S100B-positive BG (red), largely Sox2-positive 
(green), form an ordered array of cells with their cell bodies aligned in the PCL (at the bottom 
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of the molecular layer)(Fig. 6a-a’’,b-b’’); by contrast, in the mutant, S100B-positive cells show 
wide disorganization, with their cell bodies localized throughout the molecular layer (Fig. 6c-
c’’,d-d’’, quantitation in f). Sox2 immunofluorescence confirms absence of SOX2 from most 
S100B-positive cells in the mutant (Fig. 6c-c’’,d-d’’), to be compared to the wide Sox2-
positivity of S100B-positive cells in the control (Fig. 6a-a’’,b-b’’). S100B/GFAP 
immunofluorescence at 8 months confirmed that S100B-positive cells in mutant were widely 
disorganized and mislocalized, and showed highly abnormal morphology by GFAP 
immunostaining, together with a disruption of the normal, radial organization of the BG, and 
abundant ectopic BG (Fig. 6g-i, compare h, mutant, to g, control). Similar to what found in Wnt1-
Cre Sox2 mutants, deletion of Sox2 also leads to a decreased amount of BG in the PCL, as 
indicated by a similar reduced BG/PC ratio in both mutant lines (Sox2F/F;CreERT2, 2.939±0.098 
vs Sox2F/F;Cre 2.606±0.1487) compared to controls (not shown). 
These findings indicate that Sox2 is required during postnatal life to maintain BG alignment 
along PC cell bodies, and their characteristic radial morphology and organization.  
 
We further asked if postnatal Sox2 deletion would lead to motor control defects, together with 
BG abnormalities. Since Tx injection in P2 animal significantly affected newborn survival and 
for behavioural studies numerous litters are needed, we postponed the treatment to P8 and 
combined it with a second administration at P60 (see Materials & Method section). This 
protocol determined BG ectopia to an extent similar to Tx treatment at P2 (Fig. 6i).  By the 
beam-walking test, a significant difference was found between mutants and controls, with no 
differences between sexes (not shown), similarly to what observed with Wnt1-Cre mutants, 
although the extent of the motor alterations was much smaller (Fig. 7a,b). By the rotarod test, 
mutants did not perform significantly different from controls (Fig. 7c). However, when male 
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and female mutant and control mice were separately compared, mutant male mice, that 
initially performed comparably to controls (month 1), later (month 2) showed a significantly 
worse performance than controls, though the difference was clearly smaller than that found 
for Wnt1-Cre mutants (see Fig. 1b-d)(Fig. 7d). We wished to check if the abnormalities 
detected in the motor control tests (small, though statistically significant) could be affected by 
an increased anxiety in the mutants influencing motor performances. We thus performed, on 
the same mice previously evaluated in the motor control tests, a test evaluating both anxiety 
and general locomotor activity, the Open field test. No significant difference was observed 
between mutants and controls. (Fig. 7d). We conclude that postnatal Sox2 deletion in glia 
leads to mild motor control defects, based on both the beam-walking and rotarod tests. 
 
Abnormalities of glutamate transport in Sox2 mutant BG 
BG expresses the excitatory amino acid - glutamate transporter GLAST (encoded by the Slc1a3 
gene), important for the removal of glutamate from the synaptic cleft, and mutations in 
human SLC1A3 were found in patients affected by episodic ataxia (Jayadev & Bird, 2013). 
Further, BG was shown to be essential for synaptic organization and electrophysiological 
function of PCs through the action of GLAST, in studies of Slc1a3 knockout mice (Miyazaki et 
al., 2017). Glutamatergic transmission requires the involvement of glia cells to efficiently clear 
the synaptic cleft and to recycle the transmitter through a Glutamate to Glutamine (Glu/Gln) 
metabolic shuttle, in a multicomponent regulated process. We thus performed Glu uptake 
experiments in gliosomes purified from BG-enriched cell preparations of 6 wild type and 5 
Sox2-Wnt1Cre mutant mice. Gliosomes represent a well-recognised subcellular preparation 
that recapitulates molecular and functional features of the astroglial perisynaptic processes 
(Carney et al., 2014; Stigliani et al., 2006). As shown in Fig. 8, Sox2-Wnt1Cre gliosomes 
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showed a significant increase of uptake Vmax, compared to age matched control mice, with no 
significant changes in the Km values (Supporting Information Figure S4).  In parallel we 
measured the gliosomal content of endogenous Glu and Gln, and calculated the Glu/Gln ratio: 
these ratios were statistically comparable in gliosomes from Sox2-Wnt1Cre and WT BG mice 
(Supporting Information Figure S4). These data demonstrate a clear biochemical alteration of 
the Sox2-mutant BG cells, namely, Glu uptake abnormalities, without modification of 
Glu/glutamine conversion.  
 
Sox2 deletion in neural stem cells causes widespread deregulation of gene expression in in-vitro-
derived glial cells 
Previous work (Koirala & Corfas, 2010) identified genes expressed in BG at P6, or P30, or at 
both stages. To gain insight into the effect of Sox2 deletion on gene expression in glia, we 
differentiated in vitro neural stem cells obtained, at P0, both from wild type newborn mice 
and from littermates embryonically deleted for Sox2 (at E11.5, see (Favaro et al., 2009)). We 
then determined genes deregulated at day 11 of in vitro differentiation; at this stage, cells are 
postmitotic, and 90-95% of them are glial cells, with a small proportion of oligodendroglia (1-
2%) and neurons (about 5%). Finally, we compared the list of deregulated genes in 
differentiated mutant glia with those of genes expressed in BG at P6, P30, or both. Over 450 
genes, out of 1183 genes expressed at both P6 and P30 in BG, were found to be deregulated in 
Sox2-mutant glia (Supplementary Table 3); furthermore, a highly significant fraction (266 
genes) is likely to be direct SOX2 targets, based on published SOX2 ChIP-seq data (Lodato et 
al., 2013) in which SOX2 target genes were defined as being SOX2-bound in regulatory regions 
(Supplementary Table 3). These results point to an important role of Sox2 in the control of 
gene expression in differentiated glia, and possibly BG. Interestingly, among SOX2-bound, BG-
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expressed genes downregulated in Sox2-mutant cells (SOX2_UP WT_UP BOTH in 
Supplementary Table 3), several (highlighted) are potentially related to ataxia, based on 
previous publications.  Among these genes, Slc1a3 (GLAST) was Sox2-bound and moderately 
reduced, at statistically significant values, in in vitro differentiated glia, implying a potential 
effect of Sox2 deficiency on glutamate uptake; however, Slc1a3 expression, as detected by 
immunofluorescence in BG in tissue sections, was somewhat variable between different 
mutant mice, and overall not significantly different from controls (not shown). On the other 
hand, glutamate uptake by BG is a complex phenomenon, affected by many different 
components (i.e. gene products) in addition to the Slc1a3 protein amount. Future work will 
better define the relations between the altered gene expression pattern caused by Sox2 
deficiency and the increased glutamate uptake that we detected in mutant BG, as well as their 
relation with PC dysfunction and ataxia. 
 
 
Discussion 
Sox2 mutations in man cause genetically dominant defects in the central nervous system, 
including hippocampus hypoplasia, cognitive defects, motor control abnormalities, seizures, 
retina and eye defects; some of these abnormalities have been reproduced in mouse models of 
conditional Sox2 ablation (Dennert et al., 2017; Favaro et al., 2009; A. Ferri et al., 2013; Pevny 
& Nicolis, 2010; Ragge et al., 2005; Sisodiya et al., 2006). In previously studied Sox2 mutant 
mouse models, the observed defects develop prenatally, or immediately after birth, and are 
related mainly to neural stem/progenitor cells defects. An exception is represented by 
abnormalities of GABAergic interneurons morphology and postmitotic migration (Cavallaro et 
al., 2008) in the forebrain, as well as defects of differentiated glia types: Mueller glia, a 
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differentiated glial type of the eye, and oligodendroglia (Bachleda, Pevny, & Weiss, 2016; 
Hoffmann et al., 2014; Pevny & Nicolis, 2010).  
In our Wnt1Cre-Sox2flox mouse model, we report that Sox2 is important for the correct 
prenatal morphogenesis of the cerebellum, and in particular of the vermis. In addition, Sox2 
controls the correct morphology, organization/localization and development of the BG in the 
first three weeks after birth. As the BG population is mainly postmitotic after the first 
postnatal week, when BG defects arise, this finding points to important roles of Sox2 within a 
specifically differentiating, non-dividing, glia cell type. 
The cerebellar defects we observed lead to ataxic features, which are more pronounced when 
Sox2 deletion is performed prenatally, but are still observed with (partial) postnatal deletion 
within BG. 
 
Genetic mechanisms contributing to the development of ataxic features 
The significant reduction of the vermis observed in newborn Wnt1Cre Sox2 mutants is one 
plausible contributor to the ataxic features appearing shortly after birth.  In fact, vermis 
reduction, together with ataxia, was previously observed, in several mutant mouse models 
and human inherited diseases. In mouse, an experimental posterior shift (by Otx2 knock-in 
into the En1 locus) of the caudal expression boundary of the Otx2 transcription factor, a 
critical regulator of the cerebellum/mesencephalon boundary, leads to impaired vermis 
development and to ataxia (Broccoli et al., 1999). Our Sox2 mutant mimics, to a certain extent, 
the expression changes of Otx2 (and of Gbx2) observed in this mutant mouse model (see 
Supporting Information Fig. 1), suggesting that vermis reduction in the Sox2 mutant is due, at 
least in part, to Otx2/Gbx2 dysregulation. In humans, vermis reduction is observed, together 
with ataxia, in CHARGE syndrome, an autosomal dominant disorder caused by mutation of 
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CHD7 (Yu et al., 2013), a chromatin regulatory protein interacting with SOX2 (Engelen et al., 
2011). In mouse models carrying Chd7 mutations, Otx2 and Gbx2 expression boundaries are 
shifted posteriorly, similarly to what we find in Sox2 mutants (Supporting Information 
Fig.S1), and CHD7 directly binds to the Otx2 and Gbx2 regulatory regions (Yu et al., 2013), on 
sites at least partially overlapping those bound by SOX2 (Engelen et al., 2011; Lodato et al., 
2013; Yu et al., 2013). This suggests that a shared SOX2 and CHD7-controlled gene regulatory 
network, involving early Otx2 and Gbx2 regulation, may contribute to pathological features 
shared between the Sox2-deficiency and the CHARGE human syndromes. Vermis hypoplasia is 
also characteristic of Joubert and Meckel syndromes (JMS), caused by mutation of several 
different genes (Aguilar et al., 2012); interestingly, SOX2 ChIPseq experiments on cultured 
neural stem cells (NSC) (Engelen et al., 2011; Lodato et al., 2013) detect SOX2 binding to the 
promoter or to other gene sequences of various JMS genes (8 out of 17 JMS genes, mentioned 
in Aguilar et al., 2012, carry SOX2-bound promoters), a finding that was confirmed in studies 
of mouse brain-derived NSC (our unpublished observations), suggesting that Sox2 may be 
involved in a wider gene regulatory network regulating vermis development. Future 
experiments will address whether deregulation of these genes could also contribute to the 
cerebellar abnormalities in our mutants. 
Taken together, these previous results suggest that the ataxic features observed in our Wnt1-
Cre Sox2-mutant mice are due, at least in part, to the abnormalities that we observe in the 
vermis at birth. However, it is important to note that functional motor abnormalities are 
observed, although in a milder form, also in mice in which Sox2 ablation was specifically 
obtained after birth, and were not therefore related to any vermis morphological abnormality. 
This point is further discussed below. 
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The relation between ataxia and Bergmann glia abnormalities 
The observed BG abnormalities raise the issue of their possible direct involvement in the 
ataxia found in Sox2 mutants. Sox2 is expressed in BG postnatally (Fig. 3). BG ectopic location 
and cellular dysmorphology is observed in both embryonic (Wnt1-Cre) and postnatal 
(GLASTCreERT2) Sox2 mutants, (Figs. 4,6), beginning after the first week of postnatal life; it is 
first detected at P19, and persists in adults (8 months and later). Similarly to embryonic Sox2 
deletion, postnatal Sox2 deletion specifically in BG leads to ataxic features (Fig. 7), although 
the severity of the motor control defect is reduced compared to that observed in embryonic 
Sox2 mutants (Fig. 1e,f); note, however, that in postnatal mutants, the deletion of Sox2 in BG is 
incomplete (60-80%, Fig. 6), which may explain, in part, the milder phenotype. It is important 
to note that, in postnatal cerebellum, only BG and other glial cells, but neither PC nor other 
neurons, express Sox2; in addition, only BG, but not other types of glial cells, show obvious 
abnormalities. This points to BG as a likely contributor to the functional abnormalities 
observed in Sox2 mutants, both prenatal (Wnt1-Cre) and, in particular, postnatal (GLAST-
CreERT2).  
Mutation of other mouse genes leads to BG cytoarchitectural defects comparable to those in 
our mutants, accompanied by ataxia. Inactivation in BG (via a GFAP-Cre transgene) of the 
tumor suppressor adenomatous polyposis coli (APC) gene, encoding an inhibitor of the 
Wnt/beta-catenin pathway, disrupts BG architecture after P10, with translocation of their cell 
bodies to the molecular layer, loss of their pial contact and transformation into stellate-
shaped cells, leading to motor coordination deficits (X. Wang, Imura, Sofroniew, & Fushiki, 
2011). The Sox4 transcription factor gene is expressed in normal BG; intriguingly, its 
overexpression, in BG, via a hGFAP promoter leads to BG cytoarchitectural defects, resulting 
in ataxia (Hoser et al., 2007). Interestingly, ChIP studies (Lodato et al., 2013, and our 
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unpublished observations) show binding of Sox2 to the promoter regions of Sox4 and APC, 
suggesting a possible direct regulation. It is interesting to note that, in our GLASTCreERT2 Sox2 
mutant, the Sox2 deletion occurred in a subpopulation of the glial cells, BG and astroglia; the 
displaced BG cells included both Sox2-null and Sox2–positive cells. This result implies that 
non-cell autonomous mechanisms might be involved in causing cells which retain Sox2 
expression to migrate away from their normal location along the PCL. As shown in 
Supplementary Table 3, glial cells express many Sox2-bound genes encoding diffusible 
factors, whose deregulated expression, following Sox2 ablation in glia, might thus affect the 
localization of both Sox2-deleted and non-deleted BG cells. 
BG is known to play critical roles for the functionality of PCs in the mature cerebellum, and its 
defects have been shown to lead to ataxia by non-cell-autonomous mechanisms, whereby BG 
defects caused PC dysfunction. Indeed, mutant ataxin 7 (causing the autosomal dominant 
disease spinocerebellar ataxia 7, SCA7) caused neuronal degeneration when expressed in 
mouse BG via a cell-type-specific transgene (Custer et al., 2006), and mutant ataxin-1 (causing 
SCA1), when expressed in BG, contributed to non-cell-autonomous toxicity affecting PCs 
(Shiwaku et al., 2010). In our experiments, a proportion of the PC show aberrant postsynaptic 
currents of the PF-PC synapse, as expected given the connection between regulatory circuits 
operating in BG, and PC physiology (Fig. 5); on the other hand, the majority of responses were 
normal, perhaps reflecting the patchy distribution of ectopic BG.  
How BG alterations relate to the PC disturbed function in Sox2-mutant cerebellum, is difficult 
to speculate at the present time. One important fact might be the loss of the normally close 
apposition of many BG cells relative to PC in the mutant cerebellum. Additionally, the 
presence of aberrant postsynaptic responses at the PF-PC synapse, suggests that the 
dysregulation of BG-PC signalling might have impaired the normal homeostasis based on a 
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balance between synaptic potentiation and depression, leading to the generation of improper 
cortical output signals by the affected PCs. 
Collectively, our results demonstrate a novel role of Sox2 in the maintenance of morphology 
and localization of BG, as well as on at least one major biochemical activity (gliosome 
glutamate uptake) of these cells. Further, gene expression analysis of Sox2 mutant glia 
identifies a large number of potential direct Sox2 target genes (Supplementary Table 3), and 
point to a gene regulatory network that connects Sox2 to the regulation of other genes 
important in BG maintenance and in ataxia. Identifying the downstream targets of Sox2 which 
are responsible, in Sox2 mutants, for the observed BG abnormalities, will be important for a 
better understanding of mechanisms operating in BG cells to affect PC function. 
Future studies will clarify whether Sox2 expression is somehow altered in BG in ataxias 
occurring in man; additionally, it is possible that some of the transcriptional targets of Sox2 
are among the genes whose activity is altered in ataxias. The future characterization and 
understanding of the Sox2-dependent regulatory network in BG might hopefully provide 
novel targets and new perspectives for therapeutic approaches. 
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Figure legends 
 
Figure 1. Wnt1-Cre Sox2-mutant mice show defects in motor control and cerebellar 
morphology  
(a) Sox2 early conditional deletion in the midbrain-hindbrain. Sox2 in situ hybridization on 
E9.5 sagittal sections of control (Sox2F/F, left) and Sox2-deleted embryos (Sox2F/F;Cre, 
right) showing loss of Sox2 expression in the mid-hindbrain by E9.5. Fb: forebrain; Mes: 
mesencephalon; CbP: Cerebellar primordium.  
(b-d) Motor performances of Sox2F/F;Cre mutants were evaluated at rotarod test (b) and 
beam test (c,d) and compared to control littermates (Sox2FF/F+, Sox2F/+;Cre) from 1 to 8 
months of age. At the rotarod test, both Sox2F/F;Cre and Sox2F/+;Cre animals showed a 
significantly lower latency to fall compared to controls (b; Two-way Anova, main effect of 
genotype, P=0.0001); at the beam test, Sox2F/F;Cre mutants overall made more slip errors 
(b;Two-way Anova, main effect of genotype, P=0.0001) and took more time to cross the bar 
compared to controls (d, Two-way Anova, main effect of genotype, P=0.0001; Time, Two-way 
Anova, main effect of genotype, P=0.0001, main effect of time, P=0.002). Details on statistical 
analysis are reported in Table 1. 
(e,f) Sox2 early conditional deletion leads to cerebellar morphological defects. (e) Cerebellar 
morphology at P5. Two Sox2F/F;Cre mutants are shown, with “moderate” (left) and “severe” 
(right) phenotype. Vertical arrows point to the antero-posterior extension of the vermis, 
reduced in the mutants. Some enlargement of the adjacent mesencephalic lobes is also seen in 
mutants, and in controls carrying the Cre transgene as previously described (Lewis, 
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Vasudevan, O'Neill, Soriano, & Bush, 2013).  The lateral arrow in the second mutant (“severe”) 
points to a central “hole” at the mid/hindbrain boundary. The severe phenotype was observed 
in 4/44 mutant mice examined (11%). (f) Cerebellar morphology in adults, dorsal view; 
vermis lobules are numbered.  In mutants, the vermis is reduced along the antero-posterior 
axis. Scale bars: A, 200µM; B,C: 2mm. 
 
Figure 2. Adult Wnt1Cre mutant mice show morphological alterations in the cerebellar 
vermis 
(a-c) Sagittal sections of the cerebellar vermis of Sox2FF/F+ (a), Sox2F/+;Cre (b), and 
Sox2F/F;Cre (c) adult mice (8 months) display a reduction in size in the mutant accompanied 
by subtle alterations in defined fissures (asterisks in a’,a’’,b’,b’’,c’,c’’). (d) Morphometric 
measurements for each examined section comprised the evaluation of i) the PCL length along 
the entire section (green line); ii) the maximal extension along the Rostro-Caudal (R-C) axis 
axis, defined as the distance connecting the maximal convexity of the crowns of lobules V and 
IXb, and the Ventro-Dorsal (V-D) axis, corresponding to the distance connecting the 
invagination between lobules I and X and the midpoint in the crown of lobule VIb (dotted 
lines, see Methods section); iii) the thickness of the GL in each lobule (red dotted line); iv) the 
PCL length along each lobule (green line between the two green crosses) and the extension of 
the fissures separating lobules IVa/VIb (yellow line) and lobules IXb/IXc (purple line). (e) The 
extension of the entire PCL is significantly diminished in Sox2F/F;Cre compared to both 
Sox2FF/F+ and Sox2F/+;Cre mice (One-way Anova, P=0.0026). A reduction in size is also 
observed in the mutant R-C length (f; One-way Anova, P=0.0014), whereas no differences are 
detected in the V-D extension (g), as well as in GL thickness (h). (i-k) PCL length declines in 
defined lobules of the mutant compared to controls (k, lobule IV-V, One-way Anova, P=0.0195; 
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i, lobule VIb, One-way Anova, P=0.0084; j, lobules IX and X, One-way Anova, P=0.0055 and 
P=0.0124, respectively). (k-m) Mutant mice show fine alterations in foliation, as revealed by 
the absence of the fissure between lobules IXb/IXc (a’’, b’’, c’’ - violet asterisk -, l) and by the 
poor development of the fissure separating lobules VIa/VIb (a’, b’, c’ - yellow asterisk -, M; 
One-way Anova, P=0.0411). Dapi staining (blue in a-c’’) labels all cell nuclei and allows 
visualization of layering. Scale bars: a, b, c, 300 µm; a’, a’’, b’, b’’, c’, c’’, 100 µm. Details on 
statistical analysis are reported in Table 1. * P< 0.05; ** P<0.01; *** P<0.001. 
 
Figure 3. SOX2 expression in postnatal and adult cerebellum 
(a-f’) Immunofluorescence for SOX2 (green) and glial (S100B, red), or neuronal (Calbindin, 
Calb, red) markers in the control (a-d’’’) and mutant (e-f’) postnatal cerebellum. (a-b’’) SOX2 
immunofluorescence (green) in the postnatal (P7) cerebellum shows SOX2 expression in 
S100B+ astrocytes(red in a-b’), i.e. BG cells in the PCL (arrowheads in b-b’’) and parenchymal 
astrocytes of the GL and PWM (arrows in b-b’’). (c-c’’’) At P7, SOX2labelling is not detected in 
Calbindin+ PCs (red). (e-f’) Absence of Sox2 expression in mutant Sox2F/F;Cre cerebella at  
both P7 (e,e’) and  8 months (f,f’). ML, molecular layer; PCL, Purkinje cell layer, GL, granular 
layer, PWM, prospective white matter. Scale bars: A, D, E-F’, 50 μm; B-C, D’-D’’’, 20 μm; C’-C’’’, 
10 μm. 
 
Figure 4. Wnt1-Cre Sox2 mutants show postnatal BG alterations 
(a-r) Glial cells were labelled with specific markers as BLBP, S100B and GFAP in control (a-f, 
Sox2FF/F+; g-l, Sox2F/+;CRE) and in mutant (m-r, Sox2F/F;Cre) cerebella at different ages. At 
P7 (a-c; g-i; m-o) no significant differences were detected in BG progenitors distribution, as 
BG cells were similarly labelled with BLBP and S100B in the arising PCL of the three 
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genotypes. At P19 (d-d’’; j-j’’; p-p’’) ectopic S100B+ cells appeared in the mutant ML (p-p’’; 
arrows in p’) and these cells ectopic remained in the adult cerebella at 8 months (arrows in q). 
GFAP staining confirmed the presence of mislocalized BG in the mutant ML, at both P19 and 8 
months, and highlighted theaberrant multipolar morphology of these cells (arrowheads in p’’ 
and r; r’). (s) Quantification of S100B+ cells in 8 months old mutant or control cerebella 
confirmed the significant presence of ectopic BG cells in the mutant ML (Student T test, P < 
0.0001; Sox2F/F;Cre mice vs. Sox2FF/F+ and Sox2F/+;Cre mice). (t,u) Analysis of cell density 
(n. of cells/mm2) of S100B+ cells in the PCL and related ratio of S100B+ cells to PCs (u) 
showed a significant decrease of BG somata correctly aligned in the PCL (t) of 8 months old 
mutant mice (Student T tests, t, P=0.0179; u, P=0,0014; Sox2F/F;Cre vs. Sox2FF/F+ and  
Sox2F/+;Cre mice). (s-u) Being fully comparable, data from the two control genotypes were 
pooled together (see Table 2). Dapi staining (blue in a,e,g,k,m,q) labels all cell nuclei. ML, 
molecular layer; PCL, Purkinje cell layer, GL, granular layer, WM, white matter. Scale bars: a, g, 
m, 100 μm; c, d-d’’, f, hj’’, l, o-p’’, r, 50 μm; b, 20 μm; e,k,q, 30 μm; n, 10μm. Details on statistical 
analysis are reported in Table 1. * P< 0.05; ** P<0.01; *** P<0.001. 
 
Figure 5. Alteration of the PF-EPSC in adult mutant mice 
(a) Five superimposed representative traces for control (blue; Sox2FF/F+) and mutant mice 
EPSCs (red; Sox2F/F;Cre) obtained with stimulus strengths from 3 to 15 µA. (b) Amplitudes of 
Parallel Fibre (PF)- Excitatory postsynaptic potentials (EPSCs) plotted as a function of 
stimulus intensity for control (Sox2FF/F+, blue circles, n = 17) and mutant (Sox2F/F;Cre; red 
triangles, n = 16) PCs. (c) Histogram distribution of EPSC amplitudes (obtained with stimulus 
strength of 12 µA) for control (c; Sox2FF/F+) and for mutant (d) mice. (e) Cumulative 
distribution of EPSC amplitudes for control (Sox2FF/F+, blue trace) and mutant mice 
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(Sox2F/F;Cre, red trace) (P<0.0001, Kolmogorov-Smirnov test). (f) Representative traces of 
PF-EPSCs evoked by paired-pulse stimulation with an interpulse interval of 100 ms in control 
(blue; Sox2FF/F+) and mutant mice (red; Sox2F/F;Cre). (g) Time course of paired-pulse 
facilitation of PF-EPSCs in control (Sox2FF/F+, blue circles, n = 17) and mutant mice 
(Sox2F/F;Cre, red triangles, n = 16). The facilitation is expressed as the percentage of the 
second EPSC relative to the first one (mean ± SEM) and is plotted as a function of 
interstimulus interval. 
 
Figure 6. Postnatal Sox2 deletion in GLASTCreERT2Sox2 mutants causes BG alteration 
(a-d’’) Immunofluorescence analysis of Sox2F/F;CreERT2mutants after Tamoxifen (Tx) 
administration. P30 Sox2F/F;CreERT2 cerebella induced with Tx at P2 showed high numbers 
of mislocalized S100B+ BG in the ML (c-d’’), most of which have lost Sox2 expression (arrows; 
arrowheads point to cells that maintained Sox2), compared to controls (a-b’’). (d) A higher 
fraction of ectopic cells could be occasionally observed, within regions where Sox2 ablation 
had been particularly efficient (d-d’’). (e) Quantification of Sox2-ablated cells. At P30, after 
tamoxifen administration at P2, a high percentage of S100B+ cells in Sox2F/F;CreERT2mutant 
cerebella does not express SOX2, in agreement with an efficient ablation of the gene. (f) 
Fraction of ectopic S100B+BGon total S100B+BGwas significantly higher in mutant 
Sox2F/F;CreERT2 cerebella induced at P2 with respect to control littermates at P30 (Student 
T test, P = 0,0011).  (g-i) Ectopic S100B+ BG in the ML of mutant mice (arrows in h) was 
maintained at 8 months after Tx treatment at P2 orat P8 plus P60 (P8-60). Controls include 
genotypes as for Table 2.Tx, tamoxifen; ML, molecular layer; PCL, Purkinje cell layer. Scale 
bars: a-d’’, 50 μm; g,h, 20 μm. Details on statistical analysis are reported in Table 1.* P< 0.05; 
** P<0.01; *** P<0.001. 
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Figure 7. Postnatal Sox2 deletion in GLASTCreERT2 Sox2mutants causes motor control 
abnormalities   
(a-d) Motor performances of Tx-treated Sox2F/F;CreERT2 mutants were evaluated with the 
beam (a,b) and rotarod tests (c,d) and compared to those of control littermates (Controls, 
untreated) from 1 to 4 months of age. In the beam test, mutants of either sex exhibited slight 
alterations of motor behaviour compared to controls, as revealed by an increase in the 
number of slip errors (a, Two-way AnovaRM, Main effect of genotype, P<0.0454) and in the 
time needed to cross the bar (b, Two-way AnovaRM, Main effect of time, P<0.0001).  When all 
animals were pooled together, at the rotarod test no significant defects were detected in 
mutants, as showed by a similar latency to fall compared to controls (c). However, 
comparisons of mutant and control males highlighted that mutant males have a trend to 
perform in a worse way compared to controls (d, Two-way AnovaRM, Main effect of 
interaction of genotype per time, P<0.0001). (e,f) In the Open field test, both the distance 
travelled and the time spent in the center of the field were comparable in mutants and 
controls (Student T test, distance, P = 0.802; time, P = 0.7957). Further details on statistical 
analysis are reported in Supplementary Table 1. 
 
Figure 8. Wnt1-Cre Sox2 mutants show gliosomal glutamate uptake alterations 
Gliosomes from control (Sox2FF/F+, blue circles) and mutant (Sox2F/F;Cre; orange circles) 
mice were exposed for 2 min at 37 °C to increasing concentration of [3H]D-Asp (0.3, 3, 5, 30 
and 100 µM). The specific glutamate uptake for each concentration tested is expressed as 
nmol/2min. Values are expressed as nmol Glu/mg protein content / 2 min and are the mean ± 
SEM of 5 independent experiments for each group. The kinetic parameters Vmax and Km 
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values were obtained by fitting the points with the Michaelis-Menten equation 
(Vmax[Sox2FF/F+]=7.68±0.992 nmol/mg/2min, n=5; Vmax[Sox2F/F;Cre] = 12.60±1.16 
nmol/mg/2min, n=5).  *P<0.05 (Pt=-3.195=0.019) for Vmax[Sox2FF/F+] vs. Vmax[Sox2F/F;Cre] (two 
tailed Student’s t-test). No significant differences were registered for Km values (Km[Sox2FF/F+] 
= 25.70±9.57 µM n=5; Km[Sox2F/F;Cre] = 24.30±6.60 µM, n=5). 
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Supporting Information Figure and Table legends 
 
Supporting Information Figure S1.  In Sox2 mutants, Otx2 and Gbx2 show early 
alterations of expression boundaries 
(a,b) Otx2 and Gbx2 in situ hybridization on adjacent sagittal (a) or coronal (b) sections at 
E10.5 of mutants and controls (images of the mid-hindbrain boundary region are shown). (a) 
sagittal sections are shown at a lateral or medial level. Arrowheads point to the expression 
boundary of Otx2 or Gbx2, shifted posteriorly in mutants, evident in the medial region. A 
thinner neuroepithelium in mutants is visible in medial sections, corresponding to the 
prospective vermis region; this is reminiscent of a similar observation in the Gbx2 knock-out 
(J. Y. Li et al., 2002), reported to cause vermis hypoplasia. (b) Coronal sections. Arrowheads 
point to the posteriorly shifted boundary of Otx2 expression. Embryos shown in A and B are 
representative of: for coronal and sagittal sections analysis, respectively, n=5 and n=4 
Sox2F/F;Cre mutants, n=7 and n=3 Sox2F/+;Cre heterozygotes, and n=4 and n=4 Sox2F/F or 
F/+ homozygous wild type controls. Ant: anterior; Post: posterior; Mes: mesencephalon; CbP: 
cerebellar primordium; Rho: rhomboencephalon (in green in b), which includes the cerebellar 
primordium; IVv: fourth ventricle. Scale bars: 200µM.  
 
Supporting Information Figure S2.  Wnt1-Cre Sox2 mutants do not show alterations in 
the density of Purkinje cells, interneurons or astrocytes in deep cerebellar layers 
(a,b) At 8 months of age, no significant differences were detected in the density of either 
CALBINDIN-positive Purkinje cells (a) or PARVALBUMIN-expressing molecular layer 
interneurons (b) between control (Sox2FF/F+ and Sox2F/+;Cre) and mutant animals 
Page 45 of 64
John Wiley & Sons, Inc.
GLIA
  
 
45
(Sox2F/F;Cre). (c,d) Similar results were obtained for the density of S100B-positive 
astrocytes in the GL (c) and WM (d) at P19. DAPI staining (blue) labels all cell nuclei. GL, 
granular layer, WM, white matter, PCL, Purkinje cell layer, Calb, CALBINDIN, PV, 
PARVALBUMIN. Scale bars: 30µm. 
 
Supporting Information Figure S3. Wnt1-Cre Sox2 mutants do not show alterations in 
the density of cells in the oligodendroglial lineage or myelination defects 
(a) At 10 weeks of age, staining for NG2 (a, red) did not reveal differences in the density of 
oligodendrocyte progenitors between mutant (Sox2F/F;Cre) and control (Sox2FF/F+ and 
Sox2F/+;Cre) mice, either in the molecular layer (ML, a’), or in the granular layer (GL, a’’) and 
white matter (WM, a’’’). (b) Similarly, as revealed by GSTPi immunostaining (b, red), post-
mitotic differentiating oligodendrocytes showed comparable densities in all layers in both 
mutant and control mice (b’,b’’). These results were further confirmed by Olig2 
immunostaining (c-c’’’, red), which labels the entire oligodendrocyte lineage. (d-e) Anti-MBP 
immunofluorescence (red) was overall comparable in mutant (e) and control (d) mice, in both 
lobular (d’,e’) and deep (d’’, e’’) white matter. Dapi staining labels cell nuclei and allows layers 
visualization. ML, molecular layer, GL, granular layer, WM, white matter. Scale bars: 
a,b,c,d’,d’’,e’,e’’, 50µm; d,e, 200µm. 
 
Supporting Information Figure S4. Endogenous glutamate and glutamine 
quantification. High performance liquid chromatography analysis of the cytosolic 
endogenous glutamate (a) and glutamine (b) content measured in gliosomes of BG cells 
purified from control (Sox2FF/F+, blue bars) and mutant (Sox2F/F;Cre; orange bars) mice. 
Endogenous glutamate (Glu) and glutamine (Gln) content are expressed as nmol/mg of 
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gliosomal protein content and represent the mean ± SEM of 5 independent experiments for 
each experimental group (Glu[Sox2FF/F+] = 38.26±4.88 nmol/mg, n=5; Glu[Sox2F/F;Cre] = 
34.49±5.01 nmol/mg, n=5; Gln[Sox2FF/F+] = 20.12±3.98 nmol/mg, n=5; Gln[Sox2F/F;Cre] = 
24.94±5.66 nmol/mg, n=5). (c) Endogenous cytosolic glutamate/glutamine content ratio in 
gliosomes of BG cells of control and mutant mice (Glu/Gln[Sox2FF/F+] = 2.07±0.23 nmol/mg, n=5; 
Glu/Gln[Sox2F/F;Cre] = 1.52±0.17 nmol/mg, n=5). No statistically significant differences have 
been detected. 
 
Supplementary Table 1 . Details of statistical analyses.   
In most cases only comparisons leading to P<0.05 are reported; n = number of animals 
(unless differently stated). RM, repeated measures. 
 
Supplementary Table 2. Average numerical values obtained in immunofluorescence 
experiments, and statistical analysis. 
 
 
Supplementary Table 3. Genome-wide analysis of genes deregulated in glia following 
Sox2 loss, and their overlap with BG-expressed genes, and direct SOX2 binding 
 
(a) “Expression” sheet: Output of the analysis performed by NOISeq (see Methods) on RNA-
Seq data. Expression values, defined as Transcripts per Million (TPM) in three replicates of 
wild-type (WT 1-3) and Sox2-deleted cells (MUT 1-3). Genes are ordered according to 
significance of expression variation, from high to low. For each gene, the table reports: q-
value (1-FDR) output by NOISeq; the MUT/WT fold ratio; the significance of expression 
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variation at a false discovery rate (FDR) threshold of 0.01 (SIGP, +1 over-expressed in MUT, -1 
over-expressed in WT); whether or not the gene is included in the genes expressed in BG at 
postnatal day 6 (P6) (UP P6 column), at P30 (UP P30), or both (UP BOTH) (datasets from 
Koirala and Corfas 2010); whether or not the gene is SOX2-bound on the promoter or 
proximal enhancer (SOX2 in PROMOTER or SOX2 in ENHANCER) (dataset in Lodato et al., 
2013). The significance of each overlap and corresponding p-values (columns Y to AE in 
“Expression” sheet) were computed with a hypergeometric test. 
Note that, in Koirala and Korfas (2011), UP P6 are genes expressed, in BG at P6, at levels at 
least 3 times higher that at P30; UP P30 are genes expressed at P30 at levels at least 3 times 
higher that at P6; UP BOTH are genes expressed at both stages. 
 (b) “Gene lists” sheet: Lists of genes deregulated (UP MUT or UP WT) in Sox2 deleted cells 
(columns A,B), and lists of genes belonging to the different classes defined by overlap of UP 
WT or UP MUT genes and genes expressed in BG (UP P6, UP P30, or UP BOTH), and/or SOX2-
bound genes (SOX2). Genes of known potential relevance for ataxia are in bold.  
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Figure Applied Test P value F/t value Post hoc 
analyses 
Post hoc results 
Fig. 1, rotarod 
Sox2FF/F+, n=4 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=10 
Two-way 
Anova 
 
Genotype: 
P<0.0001 
 
Genotype (2, 
14)= 
70.54 
 
Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2F/F;Cre vs 
Sox2FF/F+: P<0.001 2,3 
months 
P<0.05 4,7 months 
P<0.001 5,6 months 
Sox2F/+;Cre 
vs  Sox2F/F;Cre 
P<0.001 2,3 months 
Fig. 1, beam (slips) 
Sox2FF/F+, n=4 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=10 
Two-way 
Anova 
Genotype: 
P<0.0001 
Genotype 
F(2,14)= 73.49 
Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2F/F;Cre vs 
Sox2FF/F+: P<0.01 1,4,7,8 
months 
P<0.05 3,6 months 
P<0.001 5 months 
Sox2F/F;Cre vs 
Sox2F/+;Cre:  
P<0.01 1,4 months 
P<0.05 6,8 months 
P<0.001 5 months 
Fig. 1, beam (time) 
Sox2FF/F+, n=4 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=10 
Two-way 
Anova 
Genotype: 
P<0.0001 
Time: 
P=0.002 
Genotype 
F(2,14)= 18.40 
Time F(7,14)= 
6.16 
Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2F/F;Cre vs 
Sox2FF/F+: and 
Sox2F/F;Cre vs 
Sox2F/+;Cre:  
P<0.01 2 months 
Fig. 2e 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
Main effect of 
genotype, 
P=0.0026 
(2, 6) = 18.93 Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2FF/F+ vs. 
Sox2F/F;Cre,  P=0.0045   
Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0065    
Fig. 2f 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
Main effect of 
genotype, 
P=0.014 
(2, 6) = 24.14 Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2FF/F+ vs. 
Sox2F/F;Cre, P=0.016   
Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0078 
Fig. 2i 
Lobule IV-V 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
Main effect of 
genotype, 
P=0.0195 
(2, 6) = 8.137 Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2FF/F+ vs. 
Sox2F/F;Cre, P=0.0344   
Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0442 
Fig. 2j 
Lobule VIb 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
Main effect of 
genotype, 
P=0.0084 
(2, 6) = 11.76 Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2FF/F+ vs. 
Sox2F/F;Cre, P=0.0259   
Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0125 
Fig. 2k 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
IX, Main effect 
of genotype, 
P=0.0055 
 
X, Main effect 
of genotype, 
P=0.0124 
IX, (2, 6) = 
14.02 
 
 
X, (2,6)=9.965 
Bonferroni’s 
Multiple 
Comprison 
Test 
IX, Sox2FF/F+ vs. 
Sox2F/F;Cre, P=0.0076   
Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0196 
X, Sox2FF/F+ vs. 
Sox2F/F;Cre, P=0.00144   
Fig. 2n 
VIa-VIb 
Sox2FF/F+, n=3 
Sox2F/+;Cre,  n=3 
Sox2F/F;Cre,  n=3 
One-way 
Anova 
Main effect of 
genotype, 
P=0.0411 
F(2,6)=5.693 Bonferroni’s 
Multiple 
Comprison 
Test 
 Sox2F/+;Cre vs. 
Sox2F/F;Cre, P=0.0452 
Fig. 4s BG ectopia 8 
months 
Sox2F/F;Cre,  n= 5  
Sox2F/+;Cre, n= 2 
Sox2FF/F+, n=3  
Student T test 
two tailed 
P<0.0001  
 
t(8)=7.338   
 
Fig. 4t BG density in 
PCL 
mutants: 
Sox2F/F;Cre, n=3 
controls: 
Sox2F/+;Cre, n=3 
Student T test 
two tailed 
P = 0.0179 t(7)=3.075   
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Sox2FF/F+, n=3 
Fig. 4u BG/PCL 
mutants: 
n= 3 Sox2F/F;Cre  
controls: 
n= 2 Sox2F/+;Cre 
n=3, Sox2FF/F+ 
Student T test 
two tailed 
P = 0.0014 t(7)=5.080   
Fig. 5e 
Electrophysiology 
Sox2F/F;Cre,  cells, n 
=16 
Sox2FF/F+, cells,  n = 
17 
Kolmogorov-
Smirnov test 
P < 0.0001 D = 0.68   
Fig. 6k BG ectopia Tx 
P2, 30 days survival 
mutants: 
Sox2F/F;CreERT2, n=3 
controls: 
Sox2F/+;CreERT2, n=1,  
Sox2FF or Sox2F/+, 
n=2 
Student T test 
two tailed 
P = 0,0011 t(4)=8.478   
Fig. 6n ectopia Tx P2 vs 
Tx P8-60 vs controls,  8 
months survival 
mutants: 
Sox2F/F;CreERT2-P2, 
n=4 
Sox2F/F;CreERT2-
P8/60, n=3 
controls: 
Sox2F/+;CreERT2-P2, 
n=2,  
Sox2FF or Sox2F/+P2, 
n=2 
One way 
Anova 
P = 0,0066 Genotype (2, 
8)= 
10.03 
Bonferroni’s 
Multiple 
Comparison 
Test 
Sox2F/F;CreERT2-P2 vs 
controls,  P=0.0114 
Sox2F/F;CreERT2-P8/60 
vs 
controls,  P=0.0209 
Fig. 7a beam (slips), 
both sexes 
Sox2F/F;CreERT2, 
TxP8-60, n=9 
Sox2F/F;CreERT2, no 
Tx, n=14 
Two-way RM 
Anova 
Main effect of 
genotype, 
P<0.0454 
 
F(1,21)=4.526 Bonferroni’s 
Multiple 
Comparison 
Test 
 month 1, P=0.0128 
Fig. 7b beam (time) 
Sox2F/F;CreERT2, 
TxP8-60, n=9 
Sox2F/F;CreERT2, no 
Tx, n=14 
Two-way RM 
Anova 
Main effect of 
genotype, 
P<0.0333 
Main effect of 
time, 
P<0.0001 
Fgenotype 
(1,21)=5.192 
 
Ftime 
(3,63)=8.330 
Bonferroni’s 
Multiple 
Comparison 
Test 
Genotype, month 3, 
P=0.0288 
 
Time, controls: 
month 2 vs 4, P=0.0050; 
month3 vs 4, P=0.049 
mutants: 
month 1 vs 4, P=0.0042; 
month 2 vs 4, P=0.0069 
Fig. 7d Rotarod, males 
Sox2F/F;CreERT2, 
TxP8-60, n=3 
Sox2F/F;CreERT2, no 
Tx, n=7 
Two-way RM 
Anova  
Main effect of 
interaction 
genotype x 
time, 
P<0.0001 
F(3,24)=17.05 Bonferroni’s 
Multiple 
Comparison 
Test 
month 2, P=0.0131 
Fig. 8 Vmax Student T test 
two tailed 
P=0.019 t(8)=-3.195   
Supplementary Table 1. Details of statistical analyses.  In most cases only comparisons 
leading to P<0.05 are reported; n = number of animals (unless differently stated). RM, 
repeated measures. 
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Dataset Time Genotype Mean ±  SEM n, animals Student t test 
% of ectopic BG  8 months Sox2F/+;Cre 5.179 ± 1.298 2 P=0.6445 
t(3)=0.5111 
Sox2FF/F+ 6.081 ± 0.7485 
 
3 
BG density in PCL 8 months Sox2F/+;Cre 6141 ± 396.4 3 P=0.2233 
t(4)=1440 
Sox2FF/F+ 6781 ± 201.1 3 
BG/PC 8 months Sox2F/+;Cre 3.518  ± 0.1780 
 
3 P=0.1252 
t(4)=1.935 
Sox2FF/F+ 3.939  ± 0.1256 3 
% of ectopic BG Tx P2 P30 Sox2FF/F+  6.215 ± 0.4674 2 n/a 
Sox2F/+;CreERT2 6.63 1 
% of ectopic BG Tx P2 8 months Sox2FF/F+  2.118 ± 0. 
6345 
2 P=0.2992 
t(2)=1.389 
 Sox2F/+;CreERT2 4.207 ± 1.363 
 
2 
PCs density  8 months Sox2FF/F+ 1423 ± 56,26  3 P=0.9798 
t(3)=0.02749 
Sox2F/+;Cre 1428 ± 222,2  2 
ML interneurons density 8 months Sox2FF/F+ 859,7 ± 71,81  2 P=0.1412 
t(2)=2.370 
Sox2F/+;Cre 685,7 ± 15,35  2 
GL astrocytes density P19 Sox2FF/F+ 821,4 ± 84,98 2 n/a 
Sox2F/+;Cre 761,1 1 
WM astrocytes density P19 Sox2FF/F+ 1743 ± 692,5 2 n/a 
Sox2F/+;Cre 974,8 1 
 
Supplementary Table 2. Average numerical values obtained in immunofluorescence experiments, 
and statistical analysis. 
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